Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors

Cancer Treatment Reviews · Published 2026-05-03 · DOI 10.1016/j.ctrv.2026.103145

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.ctrv.2026.103145

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles